Venus Remedies Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, faced a 5% price band limit on this session, which is the maximum daily loss allowed. The lower circuit was triggered at Rs 1,572.9, down from the previous close of Rs 1,657.8, marking a 5% decline. This price band restriction effectively froze trading at the floor price, as sellers overwhelmed demand to the point where the exchange's circuit breaker intervened. The total traded volume was 25,509 shares, with a turnover of approximately Rs 4.1 crore. Despite this turnover, the supply remained unfilled, indicating sellers queuing without buyers willing to absorb the stock at these levels. Venus Remedies Ltd thus faces a liquidity squeeze, a common feature in micro-cap stocks hitting lower circuits.

Delivery and Volume Analysis

Interestingly, delivery volumes on 23 Jul 2026 fell by 22.89% compared to the 5-day average, with only 3,190 shares delivered. This decline in delivery volume suggests that the selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. On a lower circuit day, rising delivery volumes typically indicate holders are offloading actual positions, signalling capitulation or forced selling. However, the falling delivery volume here points to a different dynamic, where intraday traders might be driving the decline rather than long-term holders exiting. Venus Remedies Ltd's delivery data thus complicates the interpretation of the selling pressure — does this suggest the stock is yet to see genuine capitulation or is the selling largely speculative?

Intraday Price Action

The intraday range was relatively narrow, with the stock touching a high of Rs 1,682 and a low of Rs 1,572.9, the lower circuit price. The weighted average price was closer to the low, indicating that most volume traded near the floor price. The stock did not open near the circuit but traded higher before cascading down to the lower circuit level, reflecting a gradual erosion of demand throughout the session. This intraday arc from Rs 1,682 to Rs 1,572.9 represents a 6.5% swing, slightly exceeding the 5% price band due to the opening price being above the previous close. Such a pattern suggests that initial buyer interest was insufficient to sustain prices, and selling pressure steadily mounted, eventually overwhelming the market. Venus Remedies Ltd's price action raises the question: is this a sign of weakening demand or a temporary imbalance that might correct soon?

Moving Averages and Trend Context

Technically, Venus Remedies Ltd trades below its 5-day and 20-day moving averages but remains above the 50-day, 100-day, and 200-day averages. This mixed moving average configuration suggests short-term weakness amid longer-term support levels. The recent three-day consecutive fall, amounting to a 9.32% decline, confirms a weakening trend in the near term. The stock's underperformance relative to its sector, which fell only 0.7% on the day, and the Sensex's 0.99% decline, further highlights the stock-specific nature of the sell-off. does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of Rs 2,232 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with a trade size of Rs 0.22 crore based on 2% of the 5-day average traded value. However, the lower circuit lock creates a significant exit risk for sellers. The circuit breaker mechanism, while preventing further price falls, also traps sellers who cannot find buyers at the floor price. This illiquidity can prolong the period of price stagnation and heighten volatility once trading resumes. For micro-cap stocks, such liquidity constraints amplify the challenges of exiting positions during sharp declines — how deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Fundamental Context

Operating within the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd has seen its stock underperform the sector by 2.08% on the day of the circuit lock. While the company’s fundamentals are not detailed here, the micro-cap status and sector volatility often contribute to heightened price swings. The recent price action reflects market sentiment rather than fundamental shifts, but the persistent selling pressure warrants close observation.

Conclusion: Severity and Liquidity Caveats

The 5% lower circuit lock at Rs 1,572.9 for Venus Remedies Ltd underscores a session dominated by unfilled supply and a lack of buyer interest. The falling delivery volumes suggest speculative selling rather than wholesale liquidation, but the technical weakness and liquidity constraints pose challenges for sellers seeking exit. The stock’s position below short-term moving averages confirms the immediate downtrend, while the micro-cap classification heightens exit risk due to limited liquidity. The circuit breaker has frozen losses but also trapped sellers, raising the question: after a 5% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today